The use of alpha-blockers in the management of benign prostatic hyperplasia.
Lowe
F C
FC
Department of Urology, St Luke's-Roosevelt Hospital Center, New York City, NY 10019.
Stark
E
E
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011467:Prostate / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000473:pathology
D000317:Adrenergic alpha-Antagonists